Prescription drug · ANDA
Meropenem NDC 55150-207
Meropenem 500 mg/1 · Injection, Powder, For solution · Intravenous · Eugia US LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55150-207-20 | 55150020720 | 10 VIAL in 1 CARTON (55150-207-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIALMarketed from Mar 27, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Meropenem
- Generic name (nonproprietary)
- meropenem
- Active ingredients
- Meropenem — 500 mg/1
- Dosage form
- Injection, Powder, For solution
- Route
- Intravenous
- Labeler
- Eugia US LLCNDC labeler code 55150
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205835
- Marketing start
- Listing expires
- Other FDA classes
- Carbapenems (Chemical structure)
- Identifiers
- Product ID 55150-207_5b3b7e4e-2c4b-433f-b422-8204068e1539SPL ID 5b3b7e4e-2c4b-433f-b422-8204068e1539SPL set ID bf1d3433-9e3f-40a0-8bff-c8ceaa8bab7cRxCUI 1722934, 1722939UNII FV9J3JU8B1UPC 0355150208302, 0355150207206
- Pharmacologic class
- Penem Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N455150020720followed by a unit qualifier and the quantityPackage 55150-0207-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Meropenem for Injection is a penem antibacterial indicated for the treatment of: Complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older only). (1.1 ) Complicated intra-abdominal infections (adult and pediatric patients). ( 1.2 ) Bacterial meningitis (pediatric patients 3 months of age and older only). ( 1.3 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of Meropenem for Injection and other antibacterial drugs, Meropenem for Injection should only be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. 1.1 Complicated Skin and Skin Structure…
Excerpt only. Read the full label for complete information.
About NDC 55150-207
- What is NDC 55150-207?
- 55150-207 is the product NDC for Meropenem, Meropenem 500 mg/1 injection, powder, for solution, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Meropenem.
- What is the active ingredient?
- Meropenem.
- Who is the labeler?
- Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Meropenem?
- 46 other product NDCs are listed under this name. See all Meropenem NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Meropenem products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Meropenem | Meropenem 500 mg/10mL | Injection, Powder, For solutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9485 | 00143-9485-10 |
| Meropenem | Meropenem 1 g/20mL | Injection, Powder, For solutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9486 | 00143-9486-10 |
| Meropenem | Meropenem 500 mg/20mL | Injection, Powder, For solutionIntravenous | Sagent Pharmaceuticals | 25021-160 | 25021-0160-20 |
| Meropenem | Meropenem 1 g/30mL | Injection, Powder, For solutionIntravenous | Sagent Pharmaceuticals | 25021-161 | 25021-0161-30 |
| Meropenem | Meropenem 1 g/20mL | InjectionIntravenous | Civica, Inc. | 72572-410 | 72572-0410-10 |
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | Civica, Inc. | 72572-412 | 72572-0412-10 |
| Meropenem | Meropenem anhydrous 2 g/1 | InjectionIntravenous | Mylan Institutional LLC | 72078-081 | 72078-0081-06 |
| Meropenem | Meropenem anhydrous 2 g/1 | InjectionIntravenous | BROOKS STERISCIENCE LIMITED | 81962-002 | 81962-0002-08 |
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | Qilu Antibiotics Pharmaceutical Co., Ltd. | 51810-502 | 51810-0502-02 |
| Meropenem | Meropenem 1 g/30mL | InjectionIntravenous | Qilu Antibiotics Pharmaceutical Co., Ltd. | 51810-503 | 51810-0503-02 |
Other NDCs under ANDA 205835
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Meropenem | Meropenem 1 g/1 | Injection, Powder, For solutionIntravenous | Eugia US LLC | 55150-208 |